Opus Genetics, Inc. · NASDAQ:IRD

Caligan Partners LP reported a 8.50% stake in Opus Genetics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Caligan Partners LP reported a 8.50% stake in Opus Genetics, Inc., 6,075,028 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
8.50%
Shares
6,075,028
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP8.50%6,075,028
JOHNSON DAVID EDWARD8.50%6,075,028

Source

View original at SEC

Related